| Product Code: ETC6746146 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Large Molecule Drug Substance CDMO Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 China Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 China Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 China Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 China Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 China Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 China Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics and biosimilars globally |
4.2.2 Growing outsourcing trend in pharmaceutical industry |
4.2.3 Advancements in biotechnology and manufacturing processes |
4.2.4 Favorable government regulations and policies supporting CDMO services |
4.2.5 Rising investments in research and development of large molecule drugs |
4.3 Market Restraints |
4.3.1 High capital investment required for setting up large molecule drug manufacturing facilities |
4.3.2 Stringent regulatory requirements and quality standards |
4.3.3 Limited expertise and skilled workforce in large molecule drug manufacturing |
4.3.4 Intellectual property protection challenges in the biopharmaceutical industry |
4.3.5 Market competition from established CDMO players |
5 China Large Molecule Drug Substance CDMO Market Trends |
6 China Large Molecule Drug Substance CDMO Market, By Types |
6.1 China Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 China Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 China Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 China Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 China Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 China Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 China Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage of revenue invested in research and development activities |
8.2 Number of strategic partnerships and collaborations with pharmaceutical companies |
8.3 Rate of adoption of innovative technologies and manufacturing processes |
8.4 Percentage of revenue derived from large molecule drug substance CDMO services |
8.5 Customer satisfaction scores and retention rates |
9 China Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 China Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 China Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 China Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 China Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 China Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 China Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here